Lannett Provides Update On Contract Renewal With Jerome Stevens Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/5/2026
- Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq
- SpaceX tumbles amid AI spending concerns; Musk outlines $1 trillion revenue target
- AMD shares slide 8% after Musk flags plans to buy Nvidia chips for SpaceX
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- New report warns China transceiver ban would hurt U.S. AI giants
- Nutanix to cut 5% of workforce, expects up to $43M in charges
- Opendoor posts Q2 revenue rise as net loss widens year over year
- Salesforce president Srini Tallapragada steps down, becomes advisor
- Walmart dips after Oppenheimer downgrades shares on difficult short-term setup
- Dave & Buster's names CFO Darin Harper as new CEO
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
Lannett Co (LCI) PT Lowered to 'Street Low' $5 at Deutsche Bank
August 20, 2018 1:46 PM EDTDeutsche Bank analyst Gregg Gilbert lowered the price target on Lannett Co (NYSE: LCI) to a street low $5.00 (from $20.00) while maintaining a Hold rating amid news the contract with Jerome Stevens Pharmaceuticals (JSP) will not be renewed.
"Our new target... More
Craig-Hallum Downgrades Lannett Co (LCI) to Neutral
August 20, 2018 12:57 PM EDTCraig-Hallum analyst Matthew Hewitt downgraded Lannett Co (NYSE: LCI) from Buy to Neutral with a price target of $7.00.
The analyst said the end of the JSP relationship creates a noticeable cash flow void.
For an analyst ratings summary and ratings... More
